Denali Therapeutics Inc (NASDAQ:DNLI) traded at $16.69 at close of the session on Friday, March 07 and made an upward move of 2.58% on its previous day’s price. Denali Therapeutics Inc has a market cap of $2.42 billion and is expected to release its quarterly
Denali Therapeutics Inc (NASDAQ:DNLI) shares, rose in value, with the stock price up by 2.19% to the previous day’s close as strong demand from buyers drove the stock to $16.30. Actively observing the price movement in the last trading, the stock closed the session at
Stocks Register is a comprehensive online news hub delivering daily updates on various facets of U.S. life, including business, technology, politics, economy, culture, sports, and noteworthy global events.
